Aberrant activation of c-Kit is associated with diminished chemo-responsiveness/chemoresistance of cancer cells and increased oncogenic signaling (e.g. in gastrointestinal stromal tumors [GISTs]) presumably by mediating an escape from apoptotic triggers [17-21]. Here, KIT is linked to cancer.